Jason Bednar
Stock Analyst at Piper Sandler
(2.32)
# 2,479
Out of 4,842 analysts
170
Total ratings
41.48%
Success rate
-2.89%
Average return
Main Sectors:
Stocks Rated by Jason Bednar
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MMSI Merit Medical Systems | Maintains: Overweight | $106 → $110 | $94.28 | +16.68% | 11 | May 23, 2025 | |
| SOLV Solventum | Upgrades: Overweight | $78 → $87 | $72.00 | +20.83% | 6 | May 19, 2025 | |
| KRMD KORU Medical Systems | Maintains: Neutral | $4.5 → $3.5 | $2.92 | +20.07% | 7 | May 8, 2025 | |
| MASI Masimo | Reiterates: Overweight | $215 → $200 | $152.97 | +30.74% | 15 | May 7, 2025 | |
| BDX Becton, Dickinson and Company | Downgrades: Neutral | $260 → $185 | $172.84 | +7.04% | 9 | May 2, 2025 | |
| LUNG Pulmonx | Reiterates: Overweight | $10 → $9 | $3.11 | +189.39% | 11 | May 1, 2025 | |
| ALGN Align Technology | Reiterates: Overweight | $235 → $250 | $182.12 | +37.27% | 30 | May 1, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $20 → $16 | $16.40 | -2.44% | 8 | Apr 30, 2025 | |
| HSIC Henry Schein | Maintains: Overweight | $83 → $77 | $73.12 | +5.31% | 7 | Apr 30, 2025 | |
| NVST Envista Holdings | Maintains: Neutral | $18 → $17 | $18.28 | -7.00% | 12 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $13 | $12.19 | +6.64% | 2 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $42 → $34 | $19.41 | +75.17% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $4.5 | $1.78 | +153.28% | 3 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $120 → $115 | $80.03 | +43.71% | 12 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $260 → $265 | $244.20 | +8.52% | 9 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $6 | $2.15 | +179.07% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 | $3.05 | +129.75% | 5 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3.5 → $1 | $0.19 | +427.15% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $372 | $554.93 | -32.96% | 4 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $95 | $71.13 | +33.56% | 1 | Apr 19, 2023 |
Merit Medical Systems
May 23, 2025
Maintains: Overweight
Price Target: $106 → $110
Current: $94.28
Upside: +16.68%
Solventum
May 19, 2025
Upgrades: Overweight
Price Target: $78 → $87
Current: $72.00
Upside: +20.83%
KORU Medical Systems
May 8, 2025
Maintains: Neutral
Price Target: $4.5 → $3.5
Current: $2.92
Upside: +20.07%
Masimo
May 7, 2025
Reiterates: Overweight
Price Target: $215 → $200
Current: $152.97
Upside: +30.74%
Becton, Dickinson and Company
May 2, 2025
Downgrades: Neutral
Price Target: $260 → $185
Current: $172.84
Upside: +7.04%
Pulmonx
May 1, 2025
Reiterates: Overweight
Price Target: $10 → $9
Current: $3.11
Upside: +189.39%
Align Technology
May 1, 2025
Reiterates: Overweight
Price Target: $235 → $250
Current: $182.12
Upside: +37.27%
DENTSPLY SIRONA
Apr 30, 2025
Maintains: Neutral
Price Target: $20 → $16
Current: $16.40
Upside: -2.44%
Henry Schein
Apr 30, 2025
Maintains: Overweight
Price Target: $83 → $77
Current: $73.12
Upside: +5.31%
Envista Holdings
Apr 30, 2025
Maintains: Neutral
Price Target: $18 → $17
Current: $18.28
Upside: -7.00%
Apr 23, 2025
Maintains: Neutral
Price Target: $15 → $13
Current: $12.19
Upside: +6.64%
Apr 23, 2025
Maintains: Overweight
Price Target: $42 → $34
Current: $19.41
Upside: +75.17%
Mar 28, 2025
Maintains: Overweight
Price Target: $5 → $4.5
Current: $1.78
Upside: +153.28%
Mar 7, 2025
Reiterates: Overweight
Price Target: $120 → $115
Current: $80.03
Upside: +43.71%
Feb 3, 2025
Maintains: Overweight
Price Target: $260 → $265
Current: $244.20
Upside: +8.52%
Nov 7, 2024
Maintains: Overweight
Price Target: $8 → $6
Current: $2.15
Upside: +179.07%
Aug 15, 2024
Reiterates: Overweight
Price Target: $7
Current: $3.05
Upside: +129.75%
Aug 7, 2024
Maintains: Overweight
Price Target: $3.5 → $1
Current: $0.19
Upside: +427.15%
Jan 3, 2024
Maintains: Outperform
Price Target: $310 → $372
Current: $554.93
Upside: -32.96%
Apr 19, 2023
Initiates: Overweight
Price Target: $95
Current: $71.13
Upside: +33.56%